ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,951Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 6645

$1.43M Total Retail Price of All Prescriptions

Rank: 147 out of 6645

806 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 806 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 18,138 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LOSARTAN POTASSIUM 991 942 1 12
AMLODIPINE BESYLATE 891 873 2 2
SIMVASTATIN 691 645 3 1
METFORMIN HCL 621 567 4 7
ATORVASTATIN CALCIUM 598 568 5 10
DIOVAN 547 531 6 19
FUROSEMIDE 523 508 7 11
ALENDRONATE SODIUM 520 510 8 14
OMEPRAZOLE 436 415 9 6
LOVASTATIN 430 418 10 15
FLUTICASONE PROPIONATE 430 415 10 26
DOXAZOSIN MESYLATE 397 382 12 81
GABAPENTIN 384 362 13 18
PROAIR HFA 379 363 14 32
AVODART 294 289 15 99
GLIMEPIRIDE 273 263 16 47
METOPROLOL SUCCINATE 272 240 17 24
ALBUTEROL SULFATE 254 240 18 112
LOSARTAN-HYDROCHLOROTHIAZIDE 247 241 19 62
TRAMADOL HCL 228 225 20 30
SPIRIVA 222 212 21 65
FLOVENT HFA 208 201 22 293
JANUVIA 201 194 23 38
ACTONEL 194 194 24 92
LISINOPRIL 189 172 25 3
FELODIPINE ER 183 170 26 105
GEMFIBROZIL 182 162 27 96
LIPITOR 175 151 28 69
BENICAR 168 166 29 84
SINGULAIR 167 166 30 76
CRESTOR 166 160 31 34
TAMSULOSIN HCL 152 148 32 22
PANTOPRAZOLE SODIUM 146 142 33 29
CLOPIDOGREL 144 137 34 36
LEVOTHYROXINE SODIUM 144 144 34 4
DIOVAN HCT 142 137 36 64
DONEPEZIL HCL 140 138 37 27
NIASPAN 138 135 38 164
LANTUS SOLOSTAR 134 121 39 139
PLAVIX 130 124 40 49
VOLTAREN 126 126 41 108
AMANTADINE 118 114 42 391
LANTUS 116 113 43 50
CROMOLYN SODIUM 114 108 44 331
CIPROFLOXACIN HCL 112 105 45 67
ZOLPIDEM TARTRATE 111 106 46 17
ISOSORBIDE MONONITRATE ER 110 109 47 66
FINASTERIDE 105 96 48 73
GLYBURIDE-METFORMIN HCL 105 104 R 48 95
TRIAMCINOLONE ACETONIDE 104 101 50 55
MECLIZINE HCL 103 99 51 122
MONTELUKAST SODIUM 100 98 52 128
HUMALOG 97 90 53 137
AZOR 96 96 54 152
MELOXICAM 89 84 55 46
ALCOHOL SWABS 87 85 56 319
NOVOLOG FLEXPEN 86 81 57 316
LEVEMIR FLEXPEN 85 84 58 237
PREDNISONE 83 78 59 57
PEN NEEDLE 81 77 60 159
NOVOFINE 32 80 73 61 509
ADVAIR DISKUS 75 71 62 45
RANITIDINE HCL 74 69 63 51
RAPAFLO 73 73 64 246
POTASSIUM CHLORIDE 73 69 64 28
GLYBURIDE 73 69 R 64 58
INSULIN SYRINGE 73 71 64 61
AMOXICILLIN 69 60 68 107
ONGLYZA 69 68 68 168
CELEBREX 66 65 70 54
CARBIDOPA-LEVODOPA 64 64 71 116
MOMETASONE FUROATE 64 59 71 292
ZOSTAVAX 63 58 73 115
ALLOPURINOL 63 60 73 31
AMMONIUM LACTATE 61 58 75 266
WARFARIN SODIUM 60 60 76 16
METOPROLOL TARTRATE 59 59 77 13
EXFORGE 59 59 77 155
CILOSTAZOL 57 57 79 202
LIDODERM 56 56 80 53
SINGLE USE SWAB 56 53 80 350
VENTOLIN HFA 56 56 80 146
LOVAZA 55 47 83 68
CARVEDILOL 54 54 84 25
HYDROCODONE-ACETAMINOPHEN 53 51 S3 85 5
BENICAR HCT 52 52 86 158
KETOCONAZOLE 51 50 87 196
IBANDRONATE SODIUM 50 47 88 147
SYMBICORT 50 46 88 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.